Biggest News Aggregation in the World
📰 Accepted News

Page 55 - Accepted News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Accepted. Real-time updates on events, politics, business and more.

INVENTIVA: Inventiva announces that its IND application for the Phase II combination trial with lanifibranor and empagliflozin in patients with NASH and T2D has been accepted by the FDA

FDA assessment concludes that the Phase II combination trial, LEGEND, may proceed The initiation of the trial is planned for H1 2022 and the publication of topline results is expected for H2 2023
New York United States Noord Holland Onno Holleboom Pascaline Clerc Aude Lepreux

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science